During the past decade, Maryland Psychiatric Research Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 20 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maryland Psychiatric Research Center" #1 sponsor was "University of Maryland, Baltimore" with 43 trials, followed by "National Institute on Drug Abuse (NIDA)" with 15 trials sponsored, "University of California, Los Angeles" with 3 trials sponsored, "Amarantus BioScience Holdings, Inc." with 1 trials sponsored and "Chengappa, K.N. Roy, MD" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maryland Psychiatric Research Center" #1 collaborator was "National Institute of Mental Health (NIMH)" with 9 trials as a collaborator, "Stanley Medical Research Institute" with 7 trials as a collaborator, "University of Maryland" with 7 trials as a collaborator, "Nathan Kline Institute for Psychiatric Research" with 4 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 4 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Maryland Psychiatric Research Center" are "Schizophrenia" (46 trials), "Schizoaffective Disorder" (12 trials), "Nicotine Dependence" (5 trials), "Cannabis Use" (3 trials) and "Schizophreniform Disorder" (3 trials). Many other conditions were trialed in "Maryland Psychiatric Research Center" in a lesser frequency.

Most popular intervention types in "Maryland Psychiatric Research Center" are "Drug" (36 trials), "Other" (6 trials), "Behavioral" (4 trials), "Dietary Supplement" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Oxytocin" (4 trials), "placebo" (3 trials), "Galantamine" (2 trials) and "Minocycline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maryland Psychiatric Research Center" are 61 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Maryland Psychiatric Research Center". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Maryland Psychiatric Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maryland Psychiatric Research Center, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 21 trials that are defined as “Not Applicable".